Regeneron Pharmaceuticals

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals

Official Twitter channel for Regeneron. We turn science into medicine for people with serious diseases. View our terms of engagement here our site
Type
B2c
Founded
1988
Raised
$8.9M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$8,900,000
Post-IPO equity - 2016
Health and Human Services
Team Size
1000+
Employees
Bloomberg Technology

Antibody Therapies Take the Spotlight as Covid-19 ‘Plan B’

MedCity News

BARDA, DoD give Regeneron $450M contract for Covid-19 antiviral drug

Forbes Tech

Regeneron’s Billionaire Cofounder Criticized After ‘All Lives Matter’ Graduation Speech

MedCity News

Regeneron vows ‘vigorous’ defense against allegations it paid kickbacks for eye drug

Bloomberg Technology

Regeneron Begins Human Trials of Coronavirus Antibody Cocktail

Xconomy

Regeneron Pays Intellia $100M to Add Hemophilia to CRISPR R&D Pact

SiliconRepublic

Regeneron announces 60 new jobs for Limerick

Bloomberg Technology

Sanofi to Sell Regeneron Stake Worth About $13 Billion

Reuters Top News

Data on arthritis drug to treat coronavirus could come within weeks: Regeneron executive

CNBC Tech

Regeneron aims to have coronavirus antibody treatment ready for human testing by early summer

Reuters Top News

U.S. judge rules for Regeneron, Sanofi in Amgen cholesterol drug...

Reuters Top News

U.S. judge rules for Regeneron, Sanofi in Amgen cholesterol drug...

Xconomy

Matching Amgen, Regeneron to Cut List Price of Heart Drug by 60%

Forbes , ENDPOINTS NEWS

Regeneron And Bluebird Team To Invent New Cell Therapies For Cancer

Science Health
Xconomy

Express Scripts Picks Regeneron Over Amgen, Cuts Heart Drug Price

Health Costs
Bloomberg

Sanofi and Regeneron's Price Gamble Is Worth It

Health
Xconomy

Regeneron to Slash Price of Cholesterol Drug After Showing It Saved Lives

Health
Bloomberg

Regeneron's Eylea Protection Is Weakening

Health Earnings
Xconomy

As AMD Race Tightens, Regeneron's Second Eye Drug Combo Falls Short

Health Earnings
Xconomy

Regeneron Touts Success in Big Asthma Drug Study, Plans FDA Filing

Robotics Health Earnings